1. Home
  2. CMC vs IMVT Comparison

CMC vs IMVT Comparison

Compare CMC & IMVT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Commercial Metals Company

CMC

Commercial Metals Company

HOLD

Current Price

$69.01

Market Cap

6.9B

Sector

Industrials

ML Signal

HOLD

Logo Immunovant Inc.

IMVT

Immunovant Inc.

HOLD

Current Price

$38.45

Market Cap

8.0B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CMC
IMVT
Founded
1915
2018
Country
United States
United States
Employees
N/A
N/A
Industry
Steel/Iron Ore
Biotechnology: Biological Products (No Diagnostic Substances)
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
6.9B
8.0B
IPO Year
1994
2019

Fundamental Metrics

Financial Performance
Metric
CMC
IMVT
Price
$69.01
$38.45
Analyst Decision
Strong Buy
Buy
Analyst Count
9
8
Target Price
$73.33
$33.00
AVG Volume (30 Days)
1.1M
960.3K
Earning Date
03-26-2026
05-28-2026
Dividend Yield
1.20%
N/A
EPS Growth
N/A
N/A
EPS
3.96
N/A
Revenue
$7,918,430,000.00
N/A
Revenue This Year
$18.81
N/A
Revenue Next Year
$6.34
N/A
P/E Ratio
$17.32
N/A
Revenue Growth
25.57
N/A
52 Week Low
$50.11
$14.32
52 Week High
$84.87
$41.23

Technical Indicators

Market Signals
Indicator
CMC
IMVT
Relative Strength Index (RSI) 53.16 49.83
Support Level $67.83 $37.53
Resistance Level $72.41 $41.22
Average True Range (ATR) 1.99 1.40
MACD 0.58 -0.38
Stochastic Oscillator 67.45 15.61

Price Performance

Historical Comparison
CMC
IMVT

About CMC Commercial Metals Company

Commercial Metals Co is a manufacturer and supplier of early-stage construction materials, including steel reinforcing bars, concrete pipes, precast products, and soil stabilization solutions. It also produces merchant bar, steel fence posts, and wire rod, serving domestic and some international markets in Europe and Asia. Its products are used in infrastructure and building projects such as highways, bridges, airports, and commercial and residential buildings.

About IMVT Immunovant Inc.

Immunovant Inc is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. Its focus is on developing IMVT-1402, a potential inhibitor of the neonatal fragment crystallizable receptor (FcRn), to address autoimmune diseases driven by high levels of pathogenic immunoglobulin G (IgG) antibodies. FcRn is involved in preventing the degradation of IgG antibodies, and inhibition of FcRn has been shown to reduce levels of total IgG and pathogenic IgG antibodies. The Company operates in a single operating segment and has one reportable segment, which includes all activities related to the discovery, development and manufacturing of its product candidates.

Share on Social Networks: